secwatch.observer — SEC 8-K summary
======================================

Issuer:     Krystal Biotech, Inc. (KRYS)
CIK:        0001711279
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0001711279-24-000023
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Krystal Biotech presents preclinical ocular gene therapy data at ARVO 2024
--------------------------------------------------------------------------

- Subretinal and suprachoroidal injections achieved widespread mCherry expression across the retina in mice.
- Vector transduced both photoreceptors (RHO+) and RPE cells (RPE65+) with minimal inflammation.
- Intravitreal injection resulted in mCherry signal in cornea, iris, and ciliary body, not retina.
- Low systemic dissemination detected; platform shows potential for inherited retinal diseases (IRDs).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711279/000171127924000023/0001711279-24-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711279/000171127924000023/krys-20240507.htm
  HTML page:      https://secwatch.observer/filing/0001711279-24-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer